vs
Monte Rosa Therapeutics, Inc.（GLUE）与泛美白银（USAS）财务数据对比。点击上方公司名可切换其他公司
泛美白银的季度营收约是Monte Rosa Therapeutics, Inc.的1.5倍（$19.1M vs $12.8M），泛美白银净利率更高（-82.3% vs -212.1%，领先129.8%），Monte Rosa Therapeutics, Inc.同比增速更快（38.5% vs -28.0%），Monte Rosa Therapeutics, Inc.自由现金流更多（$99.8M vs $-41.3M）
Monte Rosa Therapeutics是一家临床阶段生物技术企业，专注于研发靶向分子胶降解剂疗法，管线覆盖肿瘤、罕见遗传病及免疫疾病领域的未满足医疗需求，通过自主研发与行业合作推进创新疗法惠及全球患者。
泛美白银是一家总部位于加拿大的矿业企业，业务布局集中在拉丁美洲，在墨西哥、秘鲁、玻利维亚、阿根廷多国持有运营矿山及其他矿产开发项目，是美洲地区重要的贵金属开采企业。
GLUE vs USAS — 直观对比
营收规模更大
USAS
是对方的1.5倍
$12.8M
营收增速更快
GLUE
高出66.6%
-28.0%
净利率更高
USAS
高出129.8%
-212.1%
自由现金流更多
GLUE
多$141.1M
$-41.3M
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $12.8M | $19.1M |
| 净利润 | $-27.1M | $-15.7M |
| 毛利率 | — | 34.2% |
| 营业利润率 | -258.3% | — |
| 净利率 | -212.1% | -82.3% |
| 营收同比 | 38.5% | -28.0% |
| 净利润同比 | -13.5% | 2.8% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GLUEUSAS
| Q3 25 | $12.8M | $19.1M | ||
| Q2 25 | $23.2M | — | ||
| Q1 25 | $84.9M | — | ||
| Q4 24 | $60.6M | — | ||
| Q3 24 | — | $26.5M | ||
| Q4 23 | $0 | — | ||
| Q3 23 | $0 | — | ||
| Q2 23 | $0 | — |
净利润GLUEUSAS
| Q3 25 | $-27.1M | $-15.7M | ||
| Q2 25 | $-12.3M | — | ||
| Q1 25 | $46.9M | — | ||
| Q4 24 | $13.4M | — | ||
| Q3 24 | — | $-16.2M | ||
| Q4 23 | $-33.3M | — | ||
| Q3 23 | $-34.9M | — | ||
| Q2 23 | $-35.2M | — |
毛利率GLUEUSAS
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 23.6% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
营业利润率GLUEUSAS
| Q3 25 | -258.3% | — | ||
| Q2 25 | -67.1% | — | ||
| Q1 25 | 51.9% | — | ||
| Q4 24 | 21.4% | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
净利率GLUEUSAS
| Q3 25 | -212.1% | -82.3% | ||
| Q2 25 | -53.0% | — | ||
| Q1 25 | 55.2% | — | ||
| Q4 24 | 22.2% | — | ||
| Q3 24 | — | -60.9% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $208.3M | $39.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $245.8M | $50.2M |
| 总资产 | $459.8M | $234.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资GLUEUSAS
| Q3 25 | $208.3M | $39.1M | ||
| Q2 25 | $69.4M | — | ||
| Q1 25 | $78.5M | — | ||
| Q4 24 | $224.3M | — | ||
| Q3 24 | — | — | ||
| Q4 23 | $128.1M | — | ||
| Q3 23 | $59.1M | — | ||
| Q2 23 | $47.0M | — |
股东权益GLUEUSAS
| Q3 25 | $245.8M | $50.2M | ||
| Q2 25 | $268.1M | — | ||
| Q1 25 | $275.2M | — | ||
| Q4 24 | $222.9M | — | ||
| Q3 24 | — | $53.1M | ||
| Q4 23 | $179.3M | — | ||
| Q3 23 | $184.5M | — | ||
| Q2 23 | $213.7M | — |
总资产GLUEUSAS
| Q3 25 | $459.8M | $234.7M | ||
| Q2 25 | $359.6M | — | ||
| Q1 25 | $393.2M | — | ||
| Q4 24 | $438.7M | — | ||
| Q3 24 | — | — | ||
| Q4 23 | $303.8M | — | ||
| Q3 23 | $252.1M | — | ||
| Q2 23 | $278.6M | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $100.4M | $-12.5M |
| 自由现金流经营现金流 - 资本支出 | $99.8M | $-41.3M |
| 自由现金流率自由现金流/营收 | 781.5% | -216.5% |
| 资本支出强度资本支出/营收 | 5.1% | 150.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $145.0M | — |
8季度趋势，按日历期对齐
经营现金流GLUEUSAS
| Q3 25 | $100.4M | $-12.5M | ||
| Q2 25 | $-34.7M | — | ||
| Q1 25 | $-45.5M | — | ||
| Q4 24 | $128.9M | — | ||
| Q3 24 | — | $2.4M | ||
| Q4 23 | $29.6M | — | ||
| Q3 23 | $-24.7M | — | ||
| Q2 23 | $-25.3M | — |
自由现金流GLUEUSAS
| Q3 25 | $99.8M | $-41.3M | ||
| Q2 25 | $-36.4M | — | ||
| Q1 25 | $-47.1M | — | ||
| Q4 24 | $128.7M | — | ||
| Q3 24 | — | $-11.2M | ||
| Q4 23 | $27.9M | — | ||
| Q3 23 | $-26.4M | — | ||
| Q2 23 | $-31.8M | — |
自由现金流率GLUEUSAS
| Q3 25 | 781.5% | -216.5% | ||
| Q2 25 | -157.0% | — | ||
| Q1 25 | -55.4% | — | ||
| Q4 24 | 212.3% | — | ||
| Q3 24 | — | -42.2% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
资本支出强度GLUEUSAS
| Q3 25 | 5.1% | 150.8% | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | 1.9% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | — | 51.2% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
现金转化率GLUEUSAS
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.97× | — | ||
| Q4 24 | 9.59× | — | ||
| Q3 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
